BR100 Increased By (0.9%)
BR30 Increased By (1.24%)
KSE100 Increased By (1.03%)
KSE30 Increased By (1.22%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.45 Increased By ▲ 0.22 (0.7%)
CNERGY 11.78 Increased By ▲ 0.19 (1.64%)
CSIL 5.94 Increased By ▲ 0.22 (3.85%)
FCCL 61.34 Decreased By ▼ -0.20 (-0.32%)
FFL 14.84 Decreased By ▼ -0.18 (-1.2%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.02 Increased By ▲ 0.46 (8.27%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.25 Increased By ▲ 0.17 (0.16%)
NBP 174.82 Decreased By ▼ -0.46 (-0.26%)
NCPL 52.90 Increased By ▲ 0.13 (0.25%)
NPL 54.60 Increased By ▲ 0.48 (0.89%)
OGDC 318.80 Increased By ▲ 5.41 (1.73%)
PACE 9.46 Increased By ▲ 0.26 (2.83%)
PAEL 35.75 Decreased By ▼ -0.05 (-0.14%)
PIBTL 13.99 Increased By ▲ 0.52 (3.86%)
PPL 228.50 Increased By ▲ 6.69 (3.02%)
PRL 80.94 Increased By ▲ 1.86 (2.35%)
PTC 47.05 Increased By ▲ 0.20 (0.43%)
SSGC 24.10 Increased By ▲ 0.23 (0.96%)
TBL 9.30 Decreased By ▼ -0.01 (-0.11%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.85 Decreased By ▼ -0.26 (-1.04%)
TPLP 12.93 Increased By ▲ 0.42 (3.36%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.90 Increased By ▲ 0.46 (0.86%)
By

LONDON: If coronavirus vaccinations are rolled out widely, life could return to "normal" by next winter, one of the scientists behind the front-running coronavirus vaccine told British television on Sunday. Ugur Sahin, the Turkish co-founder of German firm BioN, told the BBC's The Andrew Marr Show that "this winter will be hard" without any major impact from vaccinations.

Together with US giant Pfizer, BioN is developing the leading candidate in the worldwide chase for a vaccine, "If all goes well, we will start to deliver the vaccine at the end of this year, or beginning of next year," Sahin said. "Our goal is to deliver more than 300 million doses by April next year."

Comments

Comments are closed for this article.